EcoDrugPlus

Notch Receptor 3

Ensembl ID : ENSCMIG00000005776
Gene Symbol: NOTCH3
3 Cross references
193 Possible Orthologues:

Nuclear Factor Kappa B Subunit 1

Ensembl ID : ENSCMIG00000015035
Gene Symbol: NFKB1
4 Cross references
205 Possible Orthologues:

Nuclear Factor, Erythroid 2 Like 2

Ensembl ID : ENSCMIG00000012953
Gene Symbol: NFE2L2
4 Cross references
216 Possible Orthologues:

Nuclear Receptor Subfamily 1 Group H Member 4

Ensembl ID : ENSCMIG00000012444
Gene Symbol: NR1H4
3 Cross references
388 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 1

Ensembl ID : ENSCMIG00000006507
Gene Symbol: NR3C1
2 Cross references
280 Possible Orthologues:

Nuclear Receptor Subfamily 3 Group C Member 2

Ensembl ID : ENSCMIG00000010682
Gene Symbol: NR3C2
4 Cross references
214 Possible Orthologues:

Opiate Receptor-Like 1

Ensembl ID : ENSCMIG00000011493
Gene Symbol: OPRL1
1 Cross references
202 Possible Orthologues:

Opioid Receptor Delta 1

Ensembl ID : ENSCMIG00000017620
Gene Symbol: OPRD1
3 Cross references
254 Possible Orthologues:

Opioid Receptor Mu 1

Ensembl ID : ENSCMIG00000007862
Gene Symbol: OPRM1
3 Cross references
215 Possible Orthologues:

Oxytocin Receptor

Ensembl ID : ENSCMIG00000020085
Gene Symbol: OXTR
3 Cross references
265 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Alpha

Ensembl ID : ENSCMIG00000014192
Gene Symbol: PPARA
3 Cross references
456 Possible Orthologues:

Peroxisome Proliferator Activated Receptor Delta

Ensembl ID : ENSCMIG00000017376
Gene Symbol: PPARD
3 Cross references
420 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).